Ftse Mib
36.471,75
0,12%
DAX
21.732,05
0,01%
S&P 500
6.040,53
-0,50%
NASDAQ
19.627,44
-0,28%
Bitcoin
99.761,77
-0,90%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ovid Therapeutics Inc (OVID) Ovid Therapeutics Inc (OVID) Notizie

Ovid Therapeutics Inc

OVID
0,6966
-0,0035 (-0,50%)
01 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/1/202515:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202414:00GLOBEOvid Therapeutics to Present Multiple Posters Supporting Its..
12/11/202414:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202414:03EDGAR2Form 8-K - Current report
12/11/202414:00GLOBEOvid Therapeutics Reports Business Updates and Third Quarter..
31/10/202413:00GLOBEOvid Therapeutics to Host Investor Event
26/9/202414:00GLOBEOvid Therapeutics Presents Pre-Clinical Study Results..
11/9/202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202423:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/9/202422:57EDGAR2Form 8-K - Current report
11/9/202414:00GLOBEMeg Alexander Takes on Expanded Role as President and COO at..
04/9/202414:00GLOBEOvid Therapeutics to Present at Upcoming September Investor..
13/8/202414:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202414:02EDGAR2Form 8-K - Current report
13/8/202414:00GLOBEOvid Therapeutics Reports Business Updates and Second..
08/8/202414:00GLOBEOvid Therapeutics Appoints Dr. Amanda Banks, Experienced..
02/8/202423:22EDGAR2Form 8-K - Current report
30/7/202414:00GLOBEOvid Therapeutics to Present at Upcoming August Investor..
23/7/202414:00GLOBEOvid Therapeutics Expands Scientific Advisory Board with..
10/7/202414:00GLOBEeNeuro Publishes Findings on the Anti-Convulsant Properties..
01/7/202414:00GLOBEOvid Therapeutics and Graviton Bioscience Announce Topline..
17/6/202413:10EDGAR2Form 8-K - Current report
17/6/202412:55GLOBEOvid Therapeutics Reports on Takeda’s Announcement of Phase..
07/6/202422:22EDGAR2Form 8-K - Current report
14/5/202423:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/5/202414:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202414:03EDGAR2Form 8-K - Current report
14/5/202414:00GLOBEOvid Therapeutics Reports Business Updates and First Quarter..
13/5/202413:00GLOBEOvid Therapeutics to Present at the H.C. Wainwright 2nd..
04/4/202414:00GLOBEOvid Therapeutics to Present at the 23rd Annual Needham..
08/3/202414:24EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/3/202414:20EDGAR2Form 8-K - Current report
08/3/202414:00GLOBEOvid Therapeutics Reports Business Updates, Fourth Quarter..
28/2/202414:00GLOBEOvid Therapeutics to Present at the TD Cowen 44th Annual..
27/2/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202417:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202412:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202414:00GLOBEOvid Therapeutics to Present at the Oppenheimer 34th Annual..
Apertura: 0,7198 Min: 0,66 Max: 0,7218
Chiusura: 0,7001

La tua Cronologia

NASDAQ
OVID
Ovid Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci